University of California, Santa Barbara

Grantee website Santa Barbara, California, United States
Purpose
to evaluate the enzymatic options for lowering the cost of the HIV anti-retroviral MK-8527 active pharmaceutical ingredient synthesis, which fill facilitate the future generic market entry of MK-8527 for low and middle income countries
Grantee
Division
Global Health
Date
MARCH 2025
Region served
GLOBAL
Committed amount
$250,000
Grant topic
HIV
Duration (months)
15
Grantee location
Santa Barbara, California, United States
Related work

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.